- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging drugs for schizophrenia
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume 16, Issue 2, Pages 271-282
Publisher
Informa Healthcare
Online
2011-05-13
DOI
10.1517/14728214.2011.556112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dopamine D1 Receptors, Regulation of Gene Expression in the Brain, and Neurodegeneration
- (2012) Jean Lud Cadet et al. CNS & Neurological Disorders-Drug Targets
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Acetylcholine-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
- (2010) Deranda B Lester et al. CNS Neuroscience & Therapeutics
- Paliperidone Extended Release
- (2010) Claudine M. Chwieduk et al. DRUGS
- The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures
- (2010) Mark J. Millan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia
- (2010) Emmanuel Pinard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
- (2010) Jaime E. C. Hallak et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists
- (2010) Patrik Roser et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons
- (2010) Jian-Li Hu et al. Molecular Brain
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update
- (2009) C. Chaves et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Second-generation antipsychotic long-acting injections: Systematic review
- (2009) W. Wolfgang Fleischhacker BRITISH JOURNAL OF PSYCHIATRY
- The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia
- (2009) Esther Garcia et al. CNS DRUGS
- Blonanserin
- (2009) Emma D. Deeks et al. CNS DRUGS
- Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
- (2009) O. Howes et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabis and psychosis/schizophrenia: human studies
- (2009) Deepak Cyril D’Souza et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humans
- (2009) Lieuwe Appel et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophrenia
- (2009) Hsien-Yuan Lane et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Signalling pathways associated with 5-HT6 receptors: relevance for cognitive effects
- (2009) Beatriz Marcos et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia
- (2009) Vidhi Singh et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Exposure-Response Analysis in Patients With Schizophrenia to Assess the Effect of Asenapine on QTc Prolongation
- (2009) Sunny Chapel et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Is Flunarizine a Long-Acting Oral Atypical Antipsychotic?
- (2009) Luisa W. Bisol et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lurasidone in the Treatment of Acute Schizophrenia
- (2009) Mitsutaka Nakamura et al. JOURNAL OF CLINICAL PSYCHIATRY
- Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia
- (2009) David de Lucena et al. JOURNAL OF CLINICAL PSYCHIATRY
- Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancingN-methyl-D-aspartate receptor-mediated synaptic strength
- (2009) Gang Lei et al. JOURNAL OF NEUROCHEMISTRY
- Glutamatergic (N-Methyl-D-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain?
- (2009) G. J. Marek et al. MOLECULAR PHARMACOLOGY
- Asenapine
- (2009) Herbert Y. Meltzer et al. NATURE REVIEWS DRUG DISCOVERY
- Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study
- (2009) Gaku Okugawa et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: A three-dimensional analysis with sLORETA
- (2009) Tomiki Sumiyoshi et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder
- (2009) Robert C. Smith et al. SCHIZOPHRENIA RESEARCH
- Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
- (2008) Robert Freedman et al. AMERICAN JOURNAL OF PSYCHIATRY
- Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
- (2008) Anantha Shekhar et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Effects of Galantamine on Psychopathology in Chronic Stable Schizophrenia
- (2008) Robert R. Conley et al. CLINICAL NEUROPHARMACOLOGY
- BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia
- (2008) Yona Geffen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Long-Term Efficacy and Safety of Iloperidone
- (2008) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Safety Profile of Iloperidone
- (2008) Peter J. Weiden et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Efficacy of Iloperidone in the Treatment of Schizophrenia
- (2008) Steven G. Potkin et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Mutual Prodrug Ester of GABA and Perphenazine Exhibits Antischizophrenic Efficacy with Diminished Extrapyramidal Effects
- (2008) Abraham Nudelman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study
- (2008) Daniel E. Casey et al. PSYCHOPHARMACOLOGY
- High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia
- (2008) M DYER et al. SCHIZOPHRENIA RESEARCH
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
- (2008) D GOFF et al. SCHIZOPHRENIA RESEARCH
- Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial
- (2008) Shahin Akhondzadeh et al. SCHIZOPHRENIA RESEARCH
- 5-HT7 receptors in the modulation of cognitive processes
- (2007) Agata Cifariello et al. BEHAVIOURAL BRAIN RESEARCH
- Sarcosine (N-Methylglycine) Treatment for Acute Schizophrenia: A Randomized, Double-Blind Study
- (2007) Hsien-Yuan Lane et al. BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now